Moderna's Revenue
- Moderna's annual revenue was $3.24 B in fiscal year 2024. The annual revenue decreased -$3.61 B from $6.85 B (in 2023) to $3.24 B (in 2024), representing a -52.75% year-over-year decline.
- Moderna's quarterly revenue was $966.00 M in the quarter ending Dec 2024. The quarterly revenue decreased -$1.85 B from $2.81 B (in Q4: Sept 2023) to $966.00 M (in Q4: Sept 2024), representing a -65.66% year-over-year decline.
- The highest annual revenue for Moderna was $19.26 B in fiscal year 2022.
- The lowest annual revenue was $48.04 M in fiscal year 2019.
- The average revenue was $5.96 B.
- Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
Over the past 10 years (2015 - 2024):
Learn more about Moderna's Revenue by Segment and Revenue by Region.
Check out competitors to Moderna in a side-by-side comparison.
Explore additional financial metrics for Moderna.
Definition of Revenue :
| 2016 | 101536000.00 |
|---|---|
| 2017 | 176974000.00 |
| 2018 | 122512000.00 |
| 2019 | 48036000.00 |
| 2020 | 274490000.00 |
| 2021 | 17736000000.00 |
| 2022 | 19263000000.00 |
| 2023 | 6848000000.00 |
| 2024 | 3236000000.00 |
| Mar 2017 | 35724000.00 |
|---|---|
| Jun 2017 | 35724000.00 |
| Sep 2017 | 42473000.00 |
| Dec 2017 | 88416000.00 |
| Mar 2018 | 27460000.00 |
| Jun 2018 | 25831000.00 |
| Sep 2018 | 36662000.00 |
| Dec 2018 | 32816000.00 |
| Mar 2019 | 14115000.00 |
| Jun 2019 | 10030000.00 |
| Sep 2019 | 13338000.00 |
| Dec 2019 | 10553000.00 |
| Mar 2020 | 4457000.00 |
| Jun 2020 | 28442000.00 |
| Sep 2020 | 12216000.00 |
| Dec 2020 | 229375000.00 |
| Mar 2021 | 1743000000.00 |
| Jun 2021 | 4215000000.00 |
| Sep 2021 | 4829000000.00 |
| Dec 2021 | 6949000000.00 |
| Mar 2022 | 5940000000.00 |
| Jun 2022 | 4566000000.00 |
| Sep 2022 | 3220000000.00 |
| Dec 2022 | 5084000000.00 |
| Mar 2023 | 1838000000.00 |
| Jun 2023 | 344000000.00 |
| Sep 2023 | 1831000000.00 |
| Dec 2023 | 2813000000.00 |
| Mar 2024 | 167000000.00 |
| Jun 2024 | 241000000.00 |
| Sep 2024 | 1855000000.00 |
| Dec 2024 | 966000000.00 |
2024
Moderna's annual revenue was $3.24 B in fiscal year 2024.
Moderna's quarterly revenue was $167.00 M(Q1: Mar 2024), $241.00 M(Q2: Jun 2024), $1.86 B(Q3: Sep 2024), $966.00 M(Q4: Dec 2024) in fiscal year 2024.
2023
Moderna's annual revenue was $6.85 B in fiscal year 2024.
Moderna's quarterly revenue was $1.84 B(Q1: Mar 2023), $344.00 M(Q2: Jun 2023), $1.83 B(Q3: Sep 2023), $2.81 B(Q4: Dec 2023) in fiscal year 2023.
2022
Moderna's annual revenue was $19.26 B in fiscal year 2024.
Moderna's quarterly revenue was $5.94 B(Q1: Mar 2022), $4.57 B(Q2: Jun 2022), $3.22 B(Q3: Sep 2022), $5.08 B(Q4: Dec 2022) in fiscal year 2022.
2021
Moderna's annual revenue was $17.74 B in fiscal year 2024.
Moderna's quarterly revenue was $1.74 B(Q1: Mar 2021), $4.22 B(Q2: Jun 2021), $4.83 B(Q3: Sep 2021), $6.95 B(Q4: Dec 2021) in fiscal year 2021.
2020
Moderna's annual revenue was $274.49 M in fiscal year 2024.
Moderna's quarterly revenue was $4.46 M(Q1: Mar 2020), $28.44 M(Q2: Jun 2020), $12.22 M(Q3: Sep 2020), $229.38 M(Q4: Dec 2020) in fiscal year 2020.
2019
Moderna's annual revenue was $48.04 M in fiscal year 2024.
Moderna's quarterly revenue was $14.12 M(Q1: Mar 2019), $10.03 M(Q2: Jun 2019), $13.34 M(Q3: Sep 2019), $10.55 M(Q4: Dec 2019) in fiscal year 2019.
2018
Moderna's annual revenue was $122.51 M in fiscal year 2024.
Moderna's quarterly revenue was $27.46 M(Q1: Mar 2018), $25.83 M(Q2: Jun 2018), $36.66 M(Q3: Sep 2018), $32.82 M(Q4: Dec 2018) in fiscal year 2018.
2017
Moderna's annual revenue was $176.97 M in fiscal year 2024.
Moderna's quarterly revenue was $35.72 M(Q1: Mar 2017), $35.72 M(Q2: Jun 2017), $42.47 M(Q3: Sep 2017), $88.42 M(Q4: Dec 2017) in fiscal year 2017.
2016
Moderna's annual revenue was $101.54 M in fiscal year 2024.
in fiscal year 2016.
| 2016 | 0 |
|---|---|
| 2017 | +74.30 |
| 2018 | -30.77 |
| 2019 | -60.79 |
| 2020 | +471.43 |
| 2021 | +6,361.44 |
| 2022 | +8.61 |
| 2023 | -64.45 |
| 2024 | -52.75 |
| Q1: Mar 17 | 0 |
|---|---|
| Q2: Jun 17 | 0 |
| Q3: Sep 17 | 0 |
| Q4: Dec 17 | 0 |
| Q1: Mar 18 | -23.13 |
| Q2: Jun 18 | -27.69 |
| Q3: Sep 18 | -13.68 |
| Q4: Dec 18 | -62.88 |
| Q1: Mar 19 | -48.60 |
| Q2: Jun 19 | -61.17 |
| Q3: Sep 19 | -63.62 |
| Q4: Dec 19 | -67.84 |
| Q1: Mar 20 | -68.42 |
| Q2: Jun 20 | 183.57 |
| Q3: Sep 20 | -8.41 |
| Q4: Dec 20 | 2,073.55 |
| Q1: Mar 21 | 39,007.02 |
| Q2: Jun 21 | 14,719.63 |
| Q3: Sep 21 | 39,430.12 |
| Q4: Dec 21 | 2,929.54 |
| Q1: Mar 22 | 240.79 |
| Q2: Jun 22 | 8.33 |
| Q3: Sep 22 | -33.32 |
| Q4: Dec 22 | -26.84 |
| Q1: Mar 23 | -69.06 |
| Q2: Jun 23 | -92.47 |
| Q3: Sep 23 | -43.14 |
| Q4: Dec 23 | -44.67 |
| Q1: Mar 24 | -90.91 |
| Q2: Jun 24 | -29.94 |
| Q3: Sep 24 | 1.31 |
| Q4: Dec 24 | -65.66 |
2024
Moderna’s annual revenue decreased -52.75% during fiscal year 2024 compared to 2023. It represents a decline of -$3.61 B from $6.85 B (in 2023) to $3.24 B (in 2024).
2023
Moderna’s annual revenue decreased -64.45% during fiscal year 2023 compared to 2022. It represents a decline of -$12.42 B from $19.26 B (in 2022) to $6.85 B (in 2023).
2022
Moderna’s annual revenue increased +8.61% during fiscal year 2022 compared to 2021. It represents a growth of $1.53 B from $17.74 B (in 2021) to $19.26 B (in 2022).
2021
Moderna’s annual revenue decreased +6,361.44% during fiscal year 2021 compared to 2020. It represents a decline of $17.46 B from $274.49 M (in 2020) to $17.74 B (in 2021).
2020
Moderna’s annual revenue increased +471.43% during fiscal year 2020 compared to 2019. It represents a growth of $226.45 M from $48.04 M (in 2019) to $274.49 M (in 2020).
2019
Moderna’s annual revenue decreased -60.79% during fiscal year 2019 compared to 2018. It represents a decline of -$74.48 M from $122.51 M (in 2018) to $48.04 M (in 2019).
2018
Moderna’s annual revenue decreased -30.77% during fiscal year 2018 compared to 2017. It represents a decline of -$54.46 M from $176.97 M (in 2017) to $122.51 M (in 2018).
2017
Moderna’s annual revenue increased +74.30% during fiscal year 2017 compared to 2016. It represents a growth of $75.44 M from $101.54 M (in 2016) to $176.97 M (in 2017).
Summary Table (Annual)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| 2024 | $3.24 B | -52.75% |
| 2023 | $6.85 B | -64.45% |
| 2022 | $19.26 B | +8.61% |
| 2021 | $17.74 B | +6,361.44% |
| 2020 | $274.49 M | +471.43% |
| 2019 | $48.04 M | -60.79% |
| 2018 | $122.51 M | -30.77% |
| 2017 | $176.97 M | +74.30% |
Summary Table (Quarterly)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| Q4: Dec 24 | $966.00 M | -65.66% |
| Q3: Sep 24 | $1.86 B | 1.31% |
| Q2: Jun 24 | $241.00 M | -29.94% |
| Q1: Mar 24 | $167.00 M | -90.91% |
| Q4: Dec 23 | $2.81 B | -44.67% |
| Q3: Sep 23 | $1.83 B | -43.14% |
| Q2: Jun 23 | $344.00 M | -92.47% |
| Q1: Mar 23 | $1.84 B | -69.06% |
| Q4: Dec 22 | $5.08 B | -26.84% |
| Q3: Sep 22 | $3.22 B | -33.32% |
| Q2: Jun 22 | $4.57 B | 8.33% |
| Q1: Mar 22 | $5.94 B | 240.79% |
| Q4: Dec 21 | $6.95 B | 2,929.54% |
| Q3: Sep 21 | $4.83 B | 39,430.12% |
| Q2: Jun 21 | $4.22 B | 14,719.63% |
| Q1: Mar 21 | $1.74 B | 39,007.02% |
| Q4: Dec 20 | $229.38 M | 2,073.55% |
| Q3: Sep 20 | $12.22 M | -8.41% |
| Q2: Jun 20 | $28.44 M | 183.57% |
| Q1: Mar 20 | $4.46 M | -68.42% |
| Q4: Dec 19 | $10.55 M | -67.84% |
| Q3: Sep 19 | $13.34 M | -63.62% |
| Q2: Jun 19 | $10.03 M | -61.17% |
| Q1: Mar 19 | $14.12 M | -48.60% |
| Q4: Dec 18 | $32.82 M | -62.88% |
| Q3: Sep 18 | $36.66 M | -13.68% |
| Q2: Jun 18 | $25.83 M | -27.69% |
| Q1: Mar 18 | $27.46 M | -23.13% |
| Q4: Dec 17 | $88.42 M | 0% |
| Q3: Sep 17 | $42.47 M | 0% |
| Q2: Jun 17 | $35.72 M | 0% |
| Q1: Mar 17 | $35.72 M | 0% |
